These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34853626)

  • 1. Nucleation kinetics of calcium oxalate monohydrate as a function of pH, magnesium, and osteopontin concentration quantified with droplet microfluidics.
    Ibis F; Yu TW; Penha FM; Ganguly D; Nuhu MA; van der Heijden AEDM; Kramer HJM; Eral HB
    Biomicrofluidics; 2021 Dec; 15(6):064103. PubMed ID: 34853626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The osteopontin-controlled switching of calcium oxalate monohydrate morphologies in artificial urine provides insights into the formation of papillary kidney stones.
    Langdon A; Grohe B
    Colloids Surf B Biointerfaces; 2016 Oct; 146():296-306. PubMed ID: 27362921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of osteopontin is required for inhibition of calcium oxalate crystallization.
    Wang L; Guan X; Tang R; Hoyer JR; Wierzbicki A; De Yoreo JJ; Nancollas GH
    J Phys Chem B; 2008 Jul; 112(30):9151-7. PubMed ID: 18611047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of calcium oxalate crystal growth in the presence of osteopontin isoforms: an analysis by scanning confocal interference microcopy.
    Langdon A; Wignall GR; Rogers K; Sørensen ES; Denstedt J; Grohe B; Goldberg HA; Hunter GK
    Calcif Tissue Int; 2009 Mar; 84(3):240-8. PubMed ID: 19189038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic urinary correlates of calcium oxalate dihydrate in renal stones.
    Asplin JR; Lingeman J; Kahnoski R; Mardis H; Parks JH; Coe FL
    J Urol; 1998 Mar; 159(3):664-8. PubMed ID: 9474121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microstructures of Randall's plaques and their interfaces with calcium oxalate monohydrate kidney stones reflect underlying mineral precipitation mechanisms.
    Sethmann I; Wendt-Nordahl G; Knoll T; Enzmann F; Simon L; Kleebe HJ
    Urolithiasis; 2017 Jun; 45(3):235-248. PubMed ID: 27695926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the catalysis of calcium oxalate dihydrate formation by osteopontin peptides.
    Chan BP; Vincent K; Lajoie GA; Goldberg HA; Grohe B; Hunter GK
    Colloids Surf B Biointerfaces; 2012 Aug; 96():22-8. PubMed ID: 22503630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring calcium oxalate crystallization: a constant composition approach.
    Kolbach-Mandel AM; Kleinman JG; Wesson JA
    Urolithiasis; 2015 Oct; 43(5):397-409. PubMed ID: 26016572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible inhibition of calcium oxalate monohydrate growth by an osteopontin phosphopeptide.
    Nene SS; Hunter GK; Goldberg HA; Hutter JL
    Langmuir; 2013 May; 29(21):6287-95. PubMed ID: 23611580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.
    Cerini C; Geider S; Dussol B; Hennequin C; Daudon M; Veesler S; Nitsche S; Boistelle R; Berthézène P; Dupuy P; Vazi A; Berland Y; Dagorn JC; Verdier JM
    Kidney Int; 1999 May; 55(5):1776-86. PubMed ID: 10231440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic calcium nephrolithiasis with pure calcium oxalate composition: clinical correlates of the calcium oxalate dihydrate/monohydrate (COD/COM) stone ratio.
    Guerra A; Ticinesi A; Allegri F; Pinelli S; Aloe R; Meschi T
    Urolithiasis; 2020 Jun; 48(3):271-279. PubMed ID: 31506762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggregation of Calcium Phosphate and Oxalate Phases in the Formation of Renal Stones.
    Xie B; Halter TJ; Borah BM; Nancollas GH
    Cryst Growth Des; 2015 Jan; 15(1):204-211. PubMed ID: 25598742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Parker WR; Asplin JR
    Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attachment of calcium oxalate monohydrate crystals on patterned surfaces of proteins and lipid bilayers.
    An Z; Lee S; Oppenheimer H; Wesson JA; Ward MD
    J Am Chem Soc; 2010 Sep; 132(38):13188-90. PubMed ID: 20812679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that nephrocalcin and urine inhibit nucleation of calcium oxalate monohydrate crystals.
    Asplin J; DeGanello S; Nakagawa YN; Coe FL
    Am J Physiol; 1991 Nov; 261(5 Pt 2):F824-30. PubMed ID: 1951713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of intracrystalline and surface-bound osteopontin on the degradation and dissolution of calcium oxalate dihydrate crystals in MDCKII cells.
    Thurgood LA; Sørensen ES; Ryall RL
    Urol Res; 2012 Feb; 40(1):1-15. PubMed ID: 21932131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin phosphopeptide mitigates calcium oxalate stone formation in a Drosophila melanogaster model.
    Akouris PP; Chmiel JA; Stuivenberg GA; Kiattiburut W; Bjazevic J; Razvi H; Grohe B; Goldberg HA; Burton JP; Al KF
    Urolithiasis; 2022 Dec; 51(1):19. PubMed ID: 36547746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific adsorption of osteopontin and synthetic polypeptides to calcium oxalate monohydrate crystals.
    Taller A; Grohe B; Rogers KA; Goldberg HA; Hunter GK
    Biophys J; 2007 Sep; 93(5):1768-77. PubMed ID: 17496021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
    Asokan D; Kalaiselvi P; Varalakshmi P
    Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.